{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:28:41Z","timestamp":1767853721843,"version":"3.49.0"},"reference-count":7,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,23]]},"DOI":"10.1182\/blood.2023022470","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T16:31:31Z","timestamp":1700757091000},"page":"1763-1764","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Multiple myeloma treatment: one bridge closer"],"prefix":"10.1182","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5109-0128","authenticated-orcid":false,"given":"Liliana E.","family":"Lucca","sequence":"first","affiliation":[{"name":"Cancer Research Center of Toulouse"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"21","key":"2023112316305565300_bib1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.2022019082","article-title":"Reinforced antimyeloma therapy via dual-lymphoid activation mediated by a panel of antibodies armed with bridging-BiTE","volume":"142","author":"Konishi","year":"2023","journal-title":"Blood"},{"issue":"6","key":"2023112316305565300_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa2203478","article-title":"Teclistamab in relapsed or refractory multiple myeloma","volume":"387","author":"Moreau","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"2023112316305565300_bib3","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1056\/NEJMoa2204591","article-title":"Talquetamab, a T-cell-redirecting GPRC5D bispecific antibody for multiple myeloma","volume":"387","author":"Chari","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"2023112316305565300_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-065X.1998.tb01446.x","article-title":"Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes","volume":"162","author":"Stevenson","year":"1998","journal-title":"Immunol Rev"},{"issue":"19","key":"2023112316305565300_bib5","doi-asserted-by":"crossref","first-page":"e95367","DOI":"10.1172\/jci.insight.95367","article-title":"Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens","volume":"2","author":"Bosseboeuf","year":"2017","journal-title":"JCI Insight"},{"issue":"6","key":"2023112316305565300_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"S2","key":"2023112316305565300_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.HS9.0000936256.84340.a7","article-title":"P32 majestec-1: correlative analyses of teclistamab, a B-cell maturation antigen (BCMA) X CD3 bispecific antibody, in patients with relapsed\/refractory multiple myeloma (RRMM)","volume":"7","author":"van de Donk","year":"2023","journal-title":"Hemasphere"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/21\/1763\/2089997\/blood_bld-2023-022470-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/21\/1763\/2089997\/blood_bld-2023-022470-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T16:31:36Z","timestamp":1700757096000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/21\/1763\/498732\/Multiple-myeloma-treatment-one-bridge-closer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":7,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023,11,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023022470","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]}}}